ES2292424T3 - Metodo para dioagnosticar endometricos. - Google Patents

Metodo para dioagnosticar endometricos. Download PDF

Info

Publication number
ES2292424T3
ES2292424T3 ES00901009T ES00901009T ES2292424T3 ES 2292424 T3 ES2292424 T3 ES 2292424T3 ES 00901009 T ES00901009 T ES 00901009T ES 00901009 T ES00901009 T ES 00901009T ES 2292424 T3 ES2292424 T3 ES 2292424T3
Authority
ES
Spain
Prior art keywords
markers
endometriosis
combination
leukocyte
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00901009T
Other languages
English (en)
Spanish (es)
Inventor
Daniele Gagne
Diane Gosselin
Patrice Hugo
Pierre Miron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Medical Solutions Diagnostics Inc USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Medical Solutions Diagnostics Inc USA filed Critical Siemens Medical Solutions Diagnostics Inc USA
Application granted granted Critical
Publication of ES2292424T3 publication Critical patent/ES2292424T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/364Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Devices That Are Associated With Refrigeration Equipment (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
ES00901009T 1999-01-25 2000-01-24 Metodo para dioagnosticar endometricos. Expired - Lifetime ES2292424T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11703199P 1999-01-25 1999-01-25
US117031P 1999-01-25

Publications (1)

Publication Number Publication Date
ES2292424T3 true ES2292424T3 (es) 2008-03-16

Family

ID=22370639

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00901009T Expired - Lifetime ES2292424T3 (es) 1999-01-25 2000-01-24 Metodo para dioagnosticar endometricos.

Country Status (10)

Country Link
EP (1) EP1147421B1 (https=)
JP (1) JP2002535658A (https=)
AT (1) ATE374370T1 (https=)
AU (1) AU2088800A (https=)
BR (1) BR0007702A (https=)
CA (1) CA2359200A1 (https=)
DE (1) DE60036536T2 (https=)
ES (1) ES2292424T3 (https=)
NZ (1) NZ513692A (https=)
WO (1) WO2000043789A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475298A1 (en) * 2002-02-13 2003-08-21 Kamran Shazand Cd16b as a marker for the diagnosis of endometriosis
US20050100967A1 (en) * 2003-07-11 2005-05-12 Science & Technology Corporation @ Unm Detection of endometrial pathology
US20060008876A1 (en) 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
EP1931993A2 (en) * 2005-09-14 2008-06-18 Medizinische Universität Wien Means and methods for diagnosing endometriosis
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
WO2017039751A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Mutant peptides and methods of treating subjects using the same
AU2015343202A1 (en) * 2014-11-03 2017-05-25 Bioincept, Llc PIF binding as a marker for immune dysregulation
EP3341006A4 (en) 2015-08-28 2019-03-13 BioIncept LLC COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE
WO2020218465A1 (ja) * 2019-04-26 2020-10-29 中外製薬株式会社 子宮内膜症の診断方法、病態モニタリング方法及びキット

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
US5618680A (en) * 1994-12-28 1997-04-08 Institut De Medecine De La Reproduction De Montreal Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
CA2265470A1 (en) * 1996-09-06 1998-03-12 Osteometer Biotech A/S Biochemical markers of the human endometrium

Also Published As

Publication number Publication date
EP1147421A1 (en) 2001-10-24
DE60036536D1 (de) 2007-11-08
DE60036536T2 (de) 2008-06-19
WO2000043789A1 (en) 2000-07-27
CA2359200A1 (en) 2000-07-27
BR0007702A (pt) 2002-09-10
JP2002535658A (ja) 2002-10-22
ATE374370T1 (de) 2007-10-15
AU2088800A (en) 2000-08-07
NZ513692A (en) 2001-09-28
EP1147421B1 (en) 2007-09-26

Similar Documents

Publication Publication Date Title
Gaitán et al. Accuracy of five different diagnostic techniques in mild‐to‐moderate pelvic inflammatory disease
Gagné et al. Development of a nonsurgical diagnostic tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA-125 levels
Gaucherand et al. Comparative study of three amniotic fluid markers in premature rupture of membranes: fetal fibronectin, alpha‐fetoprotein, diamino‐oxydase
ES2292424T3 (es) Metodo para dioagnosticar endometricos.
US6743595B1 (en) Method and diagnostic kit for diagnosis of endometriosis
McLachlan et al. Semen analysis: its place in modern reproductive medical practice
EP3402385A1 (en) Method for measuring tear constituents in a tear sample
US20040014063A1 (en) Il-6 detection for predicting risks of preterm delivery
Selima et al. Role of ophthalmic artery doppler in prediction of preeclampsia
Ball et al. Early embryonic demise: no evidence of abnormal spiral artery transformation or trophoblast invasion
Sellors et al. Chlamydial cervicitis: testing the practice guidelines for presumptive diagnosis
US5972594A (en) Method for screening for reproductive tract inflammation and preeclampsia using neutrophil defensins
US20030219835A1 (en) CD16b as a marker for the diagnosis of endometriosis
RU2265223C1 (ru) Способ диагностики наружного генитального эндометриоза
CN112708653B (zh) 一种用月经血预测反复流产和/或诊断反复流产的原因的检测方法
Hollegaard et al. Chlamydia trachomatis C-complex serovars are a risk factor for preterm birth
CN113832222A (zh) 生物标志物在制备用于诊断流产的试剂盒中的用途
Niklasson et al. Lactate dehydrogenase and its isoenzymes in vaginal fluid in vaginitis/vaginosis cases and in healthy controls
CA2206420A1 (en) Use of ligands specific to major histo-compatibility complex-class i antigens for diagnosing endometriosis
RU2852661C1 (ru) Способ прогнозирования варианта развития цервикальной интраэпителиальной неоплазии легкой степени, ассоциированной с вирусом папилломы человека
RU2860669C1 (ru) Способ диагностики индуцирующего влияния оксидативного стресса на апоптоз в тканях хориона при невынашивании беременности
Sánchez-Guerrero et al. Validity of screening tests for Sjögren's syndrome in ambulatory patients with chronic diseases.
Matsuda et al. T cell activation in abnormal perinatal events
Sridev et al. Sperm Assessment and Processing
Aliyeva et al. Diagnostic Value of Hematological Parameters in Pelvic Inflammatory Disease